Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.80
Delayed Data
As of Aug 31
 -0.08 / -0.23%
Today’s Change
28.25
Today|||52-Week Range
37.39
+7.81%
Year-to-Date
Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth
Aug 31 / GuruFocus News - Paid Partner Content
ARIAD Finishes Rolling NDA for Lung Cancer Drug Brigatinib
Aug 31 / Zacks.com - Paid Partner Content
Is Pfizer Paying Too Much to Buy Medivation?
Aug 31 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks to Make Your Retirement Sweeter
Aug 31 / MotleyFool.com - Paid Partner Content
Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal
Aug 31 / TheStreet.com - Paid Partner Content
Could Pfizer Face An Apple-Like Tax Surprise in the EU?
Aug 30 / MotleyFool.com - Paid Partner Content
Deere, Monsanto Slide After DOJ Files Suit To Block Precision Planting Deal; Ag Secto...
Aug 31 / Investing Channel - Paid Partner Content
Bristol-Myers Squibb misses mark with cancer drug
Aug 30 / FT.com - Paid Partner Content
Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel
Aug 31 / Zacks.com - Paid Partner Content
What's Up With Mylan's EpiPen Pricing?
Aug 30 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.88
Today’s open34.86
Day’s range34.61 - 34.94
Volume20,796,612
Average volume (3 months)23,780,244
Market cap$211.6B
Dividend yield3.45%
Data as of 4:01pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.94%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)-1.52%
P/E ratio30.8
Price/Sales4.13
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.57-0.72%
MRKMerck+0.08+0.13%
AGNPRAAllergan plc-5.16-0.62%
GSKGlaxoSmithKline+0.10+0.23%
Data as of 4:02pm ET, 08/31/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Search for Jobs